Ballicules.com

Salsalate

DISALCID

What it isSalicylate that is NOT converted to acetylsalicylic acid; arthritis.

Why this oneIt does not inhibit platelets and, unlike other NSAIDs, does not raise serum lithium.

What limits itTinnitus is the first sign of salicylate excess. GI and renal risk persist at higher doses.

FDA-approved for

FDA label

BOXED WARNING NSAID cardiovascular thrombotic risk (contraindicated for peri-operative CABG pain) and serious GI bleeding/ulceration/perforation risk
FDA dosingPopulationStartTargetMax
Rheumatoid arthritis, osteoarthritis, related rheumatic disordersAdult3000 mg/day divided3000 mg/day divided BID–TID3000 mg/day

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

⚠ BOXED WARNINGS

Cost, est. cash$10–$300/month

Generic entryBy 2023

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger3 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk3 / 4

Legacy pregnancy categoryMultiple / indication-, trimester- or formulation-dependent

Defining liabilityGI bleeding, kidney injury, hypertension and fluid retention; many agents increase lithium concentrations.

Mechanism of action: Salsalate ballicule

Salsalate ballicule: receptor binding, kinetics and half-life diagram

Open Salsalate in the interactive console ↗

Memory aids: mascots and interaction avatars

Salsalate DISALCID mascot mnemonic cartoon
“Salsa lady’s Diced salad”
“The N said... NSAID”
Salsalate weak acid avatar
weak acid

Open Salsalate in the interactive console ↗